Muhammad Shurafa - Concepedia

Author

Muhammad Shurafa

Also Known As

M S Shurafa, M Shurafa, M. S. Shurafa, M. Shurafa, MUHAMMAD SHURAFA, Muhammad S Shurafa, Muhammad S. Shurafa, Muhammad Shurafa

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Henry Ford Hospital Henry Ford Health System SWOG Cancer Research Network Wayne State University The Ohio State University

About

Muhammad Shurafa is an author at Henry Ford Hospital specializing in medicine, hematology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	459
2	Health Sciences	2	2	128
3	Natural Sciences	1	1	10
4	Biochemistry	1	1	10
5	Gastroenterology	1	1	51

Muhammad Shurafa

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study Alan F. List, Kenneth J. Kopecky, Cheryl L. Willman, Blood	2001	418
Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003) Madhav V. Dhodapkar, Joth Jacobson, Morie A. Gertz, Blood	2001	147
Clinical significance of Y chromosome loss in hematologic disease Anne E. Wiktor, Benjamin A. Rybicki, Zhe Si Piao, Genes Chromosomes and Cancer Down SyndromeCytogeneticsGenetic DisorderGeneticsY Chromosome Loss	2000	115
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Mary Varterasian, Ramzi M. Mohammad, Muhammad Shurafa, PubMed Relapsed Low-grade Non-hodgkinImmunologyPathologyPharmacotherapyImmunotherapy	2000	97
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617 Thomas R. Chauncey, Cathryn Rankin, Jeanne E. Anderson, Leukemia Research Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaHematology	2000	56
Prostaglandin F <sub>2</sub> -Alpha Bladder Irrigation for Control of Intractable Cyclophosphamide-Induced Hemorrhagic Cystitis Muhammad Shurafa, Edward J. Shumaker, Simon Cronin The Journal of Urology Urological ResearchUrologyProstaglandin F2-alphaGastrointestinal PharmacologyMedicine	1987	51
Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans Kristin G. Monaghan, Benjamin A. Rybicki, Muhammad Shurafa, American Journal of Hematology	1998	50
A Pilot Study of Thalidomide in Recurrent GI Bleeding Due to Angiodysplasias Vrushali Dabak, Philip Kuriakose, Ginny Kamboj, Digestive Diseases and Sciences MedicineSurgeryVascular SurgeryPilot Study	2007	50
Laparoscopic excision of accessory spleen Vic Velanovich, Muhammad Shurafa The American Journal of Surgery LaparoscopyVisceral SurgerySurgeryAccessory SpleenGeneral Surgery	2000	45
<i>PRDX4</i>, a member of the peroxiredoxin family, is fused to <i>AML1</i> (<i>RUNX1</i>) in an acute myeloid leukemia patient with a t(X;21)(p22;q22) Yanming Zhang, Neelmini Emmanuel, Ginny Kamboj, Genes Chromosomes and Cancer	2004	37

Page 1